A snapshot of SABA co-prescribing with ICS-formoterol maintenance and reliever therapy

Respirology. 2024 Oct;29(10):922-923. doi: 10.1111/resp.14815. Epub 2024 Aug 11.

Authors

Rebekah Lamb¹, Kyley Kerse¹, Heidi Kristono¹, Karen Oldfield¹, Richard Beasley^{1

2}

Affiliations

¹ Medical Research Institute of New Zealand, Wellington, New Zealand.
² School of Biological Sciences, Victoria University, Wellington, New Zealand.

PMID: 39129181
DOI: 10.1111/resp.14815

No abstract available

Keywords: anti‐inflammatory reliever; asthma; budesonide/formoterol; guideline; implementation.

Publication types

Letter